My Blue Dots

REDWOOD CITY, Calif.–(BUSINESS WIRE)–N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. (“Syapse”), a pioneer in precision medicine solutions for community cancer centers. The integration of Syapse into N-Power Medicine incorporates Syapse’s extensive network of community-based health systems, with more than 1,000 oncologists, its data and technology stack, and its dedicated team. N-Power partners with com

LOS ANGELES–(BUSINESS WIRE)–Prospect Medical Holdings, Inc. (“Prospect Holdings” or the “Company”) today announced that it is proceeding on a strategic pathway to realign its organizational focus outside of California, including pursuit of an agreement to sell the Roger Williams Medical Center and Our Lady of Fatima Medical Center in Rhode Island to Centurion Foundation, Inc. (the “Rhode Island Transaction”). Prospect Holdings is also continuing to engage with key stakeholders outside of Rhod

FOSTER CITY, Calif. & BALLERUP, Denmark–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) and LEO Pharma today announced a strategic partnership to accelerate the development and commercialization of LEO Pharma’s small molecule oral STAT6 (signal transducer and activator of transcription 6) programs for the potential treatment of patients with inflammatory diseases. STAT6 is the specific transcription factor required for IL-4 and IL-13 cytokine signaling, which are clinically validated tar

IRVINE, Calif.–(BUSINESS WIRE)– #ClinicalTrials–Immunis, Inc., a clinical-stage biotech developing multi-active biologics for age and disease-related immune dysregulation, has closed a $25 million Series A-1 financing round to fund two Phase 2 clinical trials. Follow-on investments from all major existing investors, notably, Remiges Ventures, Continuum Health Ventures and BOLD Capital Partners were joined by new investments from LifeSpan Vision Ventures and JLS Fund among others, including a leading global in